Inhibition of S1P by polyphenols prevents inflammation and angiogenesis: NFkappaB, a downstream effector?
Soares
Raquel
R
Azevedo
Isabel
I
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008246:Lysophospholipids / Q000378:metabolism*; D016328:NF-kappa B / Q000187:drug effects*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010636:Phenols / Q000494:pharmacology*; D059808:Polyphenols; D011427:Propiophenones / Q000494:pharmacology; D000077185:Resveratrol; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000378:metabolism; D013267:Stilbenes / Q000494:pharmacology; D027843:Vitis / Q000737:chemistry
D000893:Anti-Inflammatory Agents; D005419:Flavonoids; D008246:Lysophospholipids; D016328:NF-kappa B; D010636:Phenols; D059808:Polyphenols; D011427:Propiophenones; D013267:Stilbenes; C060506:sphingosine 1-phosphate; D013110:Sphingosine; D000077185:Resveratrol; C104536:xanthohumol